Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases

LJ Kosse, NT Jessurun, HE Vonkeman, SW Tas, MT Nurmohamed, F Hoentjen, Martijn van Doorn, EP van Puijenbroek, BJF Bemt, M Boersma - de Vries

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)1521-1528
Number of pages8
JournalExpert Opinion on Drug Safety
Issue number11
Publication statusPublished - 2020

Research programs

  • EMC OR-01

Cite this